The collagen-platelet interaction is central to haemostasis and may be a critical determinant of arterial thrombosis, where subendothelium is exposed after rupture of atherosclerotic plaque. Recent research has capitalized on the cloning of an important signalling receptor for collagen, glycoprotein VI, which is expressed only on platelets, and on the use of collagen-mimetic peptides as specific tools for both glycoprotein VI and integrin ␣2␤1. We have identified sequences, GPO and GFOGER (where O denotes hydroxyproline), within collagen that are recognized by the collagen receptors glycoprotein VI and integrin ␣2␤1 respectively, allowing their signalling properties and specific functional roles to be examined. Triple-helical peptides containing these sequences were used to show the signalling potential of integrin ␣2␤1, and to confirm its important contribution to platelet adhesion. Glycoprotein VI appears to operate functionally on the platelet surface as a dimer, which recognizes GPO motifs that are separated by four triplets of collagen sequence. These advances will allow the relationship between the structure of collagen and its haemostatic activity to be established.
Introduction
The collagen gene product requires proteolytic cleavage to remove Nand C-terminal propeptides as the monomeric triple helix is secreted from the cell, allowing its assembly into highly ordered fibrils which constitute the collagen fibre, the primary structural component of the vertebrate organism. This chapter, however, addresses the function of collagen not as a protease substrate nor as an inert structural protein, but rather as an important modulator of cell function which acts through specific adhesive and signalling receptors expressed on the cell surface. A vivid example of the capacity of collagen to modulate cell function is provided by the human platelet, which must respond over a timescale of a few tens of seconds to prevent loss of blood should there be life-threatening damage to the vasculature. The platelet's haemostatic response is initiated by the dual adhesive and activatory properties of vessel wall collagens, notably the fibrillar collagens I and III, along with other subendothelial collagens such as collagens IV and VI; the circulating platelet scans the vascular endothelium for damage that exposes such collagens.
Significant progress has been made over the past 10 years in understanding the molecular detail of this complex process, including the precise sequences within collagen that are recognized by collagen receptors, the molecular architecture of the receptors themselves and the signals that arise from the interaction between the two (reviewed in [1] ). This increasing body of knowledge underpins the development of tools with which to disrupt platelet recruitment and the deposition of platelet thrombi on subendothelial collagens at the site of rupture or fissure of an atherosclerotic plaque. An inappropriate haemostatic response of platelets in this disease setting is a primary cause of sudden heart attack and unstable angina, which gives great impetus to the studies described below.
Collagen structure and primary sequence
The triple-helical structure of collagen has been understood for many years and will not be described in great depth here. Polyproline helix formation in the nascent collagen chains is favoured by the presence of proline residues, and the propensity of collagen to form triple helices is enhanced by post-translational hydroxylation of proline in the XЈ position of the model GXXЈ triplet, GPP (Gly-Pro-Pro), taking place in the endoplasmic reticulum. The resulting GPO triplets (where O is hydroxyproline) form approx. 10% of the primary sequence of collagen, although both P and O occur frequently in other X and XЈ positions respectively and contribute to the secondary structure and stability of the triple helix. Diversity of sequence within this conserved GXXЈ framework has proved to be both important and specific for the recognition of cell-surface collagen receptors, not least because native triple-helical structure is required for the recognition of collagens by platelets and other cells.
Collagen receptors
Knowledge about collagen receptors is increasing rapidly, especially in relation to the collagen-binding integrins. A subset of those integrins that contain an inserted domain, or I-domain, within their ␣ subunit is now considered to be the only class that interacts directly with the collagens [2, 3] . Four ␤1 integrins, i.e. ␣1␤1, ␣2␤1, ␣10␤1 and ␣11␤1, fall into this category, and, although these are expressed in many human tissues, platelets contain only ␣2␤1. The collagen sequences described below appear to bind to each of these integrins [4, 5] , and although there may be selectivity of a given collagen sequence for specific integrin I-domains, as has been established for ␣1␤1 [4, 6, 7] , final understanding of their interaction has yet to be achieved.
The platelet also expresses several other types of collagen receptor, the best characterized being the immunoglobulin-superfamily member glycoprotein VI (GpVI), a key platelet signalling receptor [8] . Work from this laboratory has identified sequences within collagen that bind integrin ␣2␤1 [4, 9] or activate GpVI [10, 11] ; however, apart from these two, the molecular understanding of collagen receptors is at a rudimentary level. GpV has been shown to bind collagen [12] , the scavenger receptor CD36 is considered to have an ancillary role in platelet activation by collagen [13] , and receptors specific for either collagen I or collagen III have also been identified [14, 15] . A specific sequence in collagen III, KOGEOGPK, has been proposed as a recognition motif [14, 16] . The linear peptide has been used as a receptor antagonist and affinity ligand, yet, in our hands, this sequence in triple-helical form does not appear to be active. The rest of this chapter will be devoted to collagen-binding integrins and GpVI.
Multi-site model for the platelet-collagen interaction
The ability of collagens to stimulate platelets was discovered over 40 years ago [17] , and was shown during the subsequent decades to be an active process that induces cytoskeletal activity, secretion of platelet granule contents and up-regulation of the fibrinogen receptor integrin ␣IIb␤3, leading to platelet aggregation. A line of evidence originating in platelet deficiencies and autoimmunities in Japanese patients [18, 19] revealed the involvement of GpVI in platelet activation by collagen [20, 21] . Overall, the interaction must be sufficient to allow collagens of the vessel wall to capture platelets from the circulation under the high shear stress of the arterial circulation, and experiments using platelets from a patient lacking integrin ␣2␤1 [22, 23] , along with the development of blocking antibodies [24] , indicated a role for this integrin in haemostasis and especially in adhesion to collagen under both static [25] and flow [26] conditions. Thus platelet collagen receptors combine to express both adhesive and activatory functions. During the 1980s, chemical modification of collagens [27] and fragmentation using cyanogen bromide [28] revealed that these two properties need not reside at the same locus within collagens. Thus the two-site, two-step model was born, which in its simplest form stated that the platelet-vessel-wall interaction occurs in two stages: an adhesive step, quite quickly shown to require integrin ␣2␤1, and an activatory step, currently identified with GpVI. What is not yet clear is the extent to which these discrete functions may overlap or regulate one another, and whether the other minor collagen receptors alluded to above contribute to thrombus formation under physiological conditions. It should be emphasized that, as a pre-requisite for the capture of platelets under shear stress, indirect interaction between collagen and GpIb is mediated by von Willebrand factor, which allows the platelet to roll across the subendothelium, where it can be arrested by higher-affinity interactions mediated through integrin ␣2␤1. These several interactions are summarized schematically in Figure 1 .
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GpVI and integrin ␣2␤1 are expressed in similar numbers on the platelet surface, with about 1000-3000 copies of each. Expression of each receptor correlates with polymorphisms: the silent C807T for the integrin ␣2 gene, and the five linked dimorphisms of GpVI that occur as two common alleles, designated a and b. The significance of the latter will be discussed below. A link between high expression levels of ␣2␤1 [29] or of the b/b genotype of GpVI [30] and thrombosis has been reported for certain populations. On the other hand, deficiencies in either receptor cause haemostatic dysfunction [19, 22] . Recently, studies using either GpVI-deficient mouse platelets (achieved either by depletion using an anti-GpVI antibody, JAQ1, or by knockout of the Fc receptor ␥-chain with which GpVI is co-expressed) or ␣2␤1-deficient mouse platelets (␣2 or ␤1 knockouts) have re-examined the relative importance of these collagen receptors. Some studies emphasize the role of GpVI in primary adhesion [31] [32] [33] , whereas others support an adhesive role of ␣2␤1 [34] . Such methods are lacking for the study of human platelets. However, a recent study in our laboratory using a single-chain antibody to block human GpVI, along with specific blockade of ␣2␤1 using the peptide described below, has indicated that a complex interplay between collagen and these receptors, along with GpIb, is required for platelets to be captured by collagen-coated surfaces under flow (P.R.-M. Siljander, I.C.A. Munnix, P.A. Smethurst, H. Deckmyn, T. Lindhout, W.H. Ouwehand, R.W. Farndale and J.W.M. Heemskerk, unpublished work). It seems that in mice there may be a stronger dependence on GpVI for the adhesive as well as the activatory steps than is the case in humans, causing us to question the use of mouse models as the sole basis for investigating the role of collagen receptors in thrombosis. Other sequences Figure 1 The interaction of collagen with platelets. The known sequences in collagen, i.e. GFOGER and GPO motifs, interact with integrin ␣2␤1 and GpVI respectively, whose major functions are adhesion and signalling. Indirect adhesion is mediated by von Willebrand factor (vWf) and platelet GpIb. Little is known of the sequences in collagen that recognize von Willebrand factor or other, less well characterized, receptors.
Recognition of integrin ␣2␤1
The non-uniform distribution of integrin ␣2␤1 recognition sites among triple-helical peptides of collagens I and III produced by cyanogen bromide fragmentation (CB peptides) [35] [36] [37] supported a mapping approach using synthetic peptides. These comprised overlapping stretches of the collagen (guest) sequence under test flanked by GPP or GPO (host) polymers [9] . Amino acid substitution allowed the precise detail of each recognition motif to be established. Finally, the sequence GFOGER was identified as the ligand for ␣2␤1 within the CB3 fragment of the collagen I ␣1 chain [4] . Subsequent work showed weaker recognition of the integrin by the sequences GLOGER and GASGER. The latter in particular appears to be a low-affinity motif, and together these sequences may be sufficient to account for the capacity of recombinant I-domains to bind collagen I, as determined using rotary shadowing as a probe [38] .
Co-crystallization of a short GFOGER-containing collagen peptide with the ␣2 I-domain revealed the molecular detail of the interaction [39] , which occurs primarily via the middle strand of the staggered triple helix. Key features are that the glutamate side chain is fully extended to allow co-ordination of its carboxylate group to the bivalent cation, such as Mg 2+ , in the MIDAS (metal ion-dependent adhesion site), such that the shorter aspartate side chain would be unlikely to serve this function, as confirmed by experimental findings. Other interactions include hydrophobic binding between phenylalanine and a pocket on the I-domain surface between Gln 215 and Asn 154 , and a salt bridge between arginine and a negatively charged locus centering on Asp 219 . Binding is stabilized further by both hydrophobic and electrostatic interaction between the trailing strand and the I-domain, as well as by hydrogen bonds formed between main-chain carbonyls in both peptide strands and the I-domain.
The relatively non-specific nature of the bonds between the two structures outside the MIDAS suggested that GEK sequences might be active. A model peptide did indeed bind the ␣2 I-domain, but we have not pursued this finding. Other hydrophobic residues might substitute for phenylalanine, as shown already in the sequence GLOGER. Further, alignment of the sequences of the fibrillar collagen ␣-chains revealed some interesting similarities. Two novel sequences, GAOGER and GLSGER, occupied the same position in collagen III as GLOGER and GASGER in the collagen I ␣1 chain. The identity between the collagen fragments ␣1(III)CB4 and ␣1(I)CB3, both of which recognize integrins, had already been noted [35, 40] , as had the alignment of GAOGER (collagen III) with GFOGER (collagen I). The cyanogen bromide methodology, however, fails to address another possible integrin-binding sequence, GMOGER, since it would be cleaved at methionine. This was addressed by synthesizing peptides that confirmed the integrin-binding potential of both GMOGER and GLSGER. Again, alignment of sequences shows that GMOGER occurs in the same position relative to GFOGER and GAOGER in collagens I and III respectively, as summarized in Figure 2 . Thus it appears that the spatial relationship between integrin sequences within collagen ␣-chains is conserved, underscoring their importance and suggesting that the organization
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of collagen might have an essential impact on integrin function, perhaps in the way that collagen might signal by clustering integrins.
GpVI recognition
Our interest in GpVI recognition arose from the use of synthetic peptides in the search for other receptor-binding motifs. In 1995, control peptides comprising the triple-helical GPO hosts were found to be potent platelet activators without binding to integrin ␣2␤1 [10] . In contrast, GpVI-deficient platelets did not respond to these GPO polymers [41] , and a series of studies ensued in which the use of this or other similar peptides, designated collagen-related peptide (CRP), allowed the signalling pathways downstream from GpVI to be elucidated ( [42] [43] [44] ; reviewed in [45, 46] ). GpVI itself was cloned and sequenced in 1999 [8] , paving the way for the use of recombinant protein in a number of contexts, including the development of antibodies against human GpVI.
CRP contains ten GPO triplets and forms a very stable triple helix. The length of the rope-like CRP molecule far exceeds the dimensions of the ectodomain of GpVI, which immediately suggests that the recognition motif for GpVI must correspond to a shorter stretch of collagen sequence. Analogy with integrin ␣2␤1 recognition suggests that two triplets might be ample to span the collagen-binding site of GpVI, an idea supported by modelling based on the homologous natural killer receptor, NKR1. GPO triplets are common within the collagenous triple helix, but seldom occur in tandem. However, peptides comprising repeated GPP triplets are very poor platelet ligands at best [11] , showing that hydroxyproline is critical for the CRP-GpVI interaction. At present, there is little direct evidence for the involvement of any collagen triplet other than GPO, an important topic that is discussed further below. Figure 2 GER sequences from collagens I and III that recognize integrin ␣2␤1. Numbers show the position of the initial Gly residue of each sequence within the corresponding procollagen gene product, including the signal sequence. The capacity of these motifs to bind integrin and platelets was verified as described previously [4] , and darker grey shading reflects strength of binding.
To investigate the minimum GpVI recognition motif in collagen, a set of model peptides (shown in Table 1 ) was used in platelet adhesion, aggregation and signalling assays. In this set, increasing numbers of GPO triplets were hosted within inert GPP polymers, so that the overall peptide length was conserved at ten triplets. In addition, a Cys-containing triplet was introduced at each end to allow cross-linking (see below). The parent GPP host was silent, supporting no discernible platelet adhesion or activation. Platelet adhesion commenced with the inclusion of a single GPO triplet, rising progressively with up to four GPOs. Only a modest further increase in platelet adhesion occurred with CRP (ten GPO triplets). Model peptides with two separated GPO triplets or GPOGPO motifs showed progressive increases in reactivity compared with peptides containing a single GPO. These unpublished data are summarized in Figure 3 .
Given that sub-optimal platelet adhesion can occur to peptides that are sufficiently long to fully occupy the putative collagen-binding surface of the receptor, specifically peptide H, it follows that additional binding must result from the co-operative interaction of more than one copy of GpVI. Thus we deduce that GpVI on the platelet surface operates functionally as a dimer, presumably linked by the disulphide-linked dimeric Fc receptor ␥-chain with which it interacts. This concept is supported by the increased adhesion of platelets to peptides with separated GPO triplets. Recently, the use of ectodomains of GpVI expressed as Fc fusion proteins led to a similar proposal [47] .
The gain in binding that occurs as the GPO nucleus increases from one to two triplets suggests that the footprint of GpVI upon collagen ideally comprises two adjacent GPO triplets, although the presence of GPP, being of similar structure, adjacent to GPO does not prevent a weaker interaction occurring with a single GPO residue. Consideration of the disposition of hydroxyproline residues between adjacent strands of the triple helix gives further insights into the possible structure of the GpVI-binding surface of collagen. One model that is consistent with the data presented above is that a single GPO triplet within the primary sequence of the peptide will result in GPO triplets in adjacent strands of the triple helix being adjacent to each other. Such a structure will bind GpVI, albeit weakly. Placing a second GPO triplet adjacent to the first in the primary sequence of the peptide will complete a triangle of GPO triplets, which may constitute the optimum GpVI recognition motif, spanning two chains of the triple helix. This concept is shown in Figure 4 .
Signalling through GpVI
The same peptide set allowed us to investigate the mechanisms of platelet signalling through GpVI, using aggregation and protein tyrosine phosphorylation as indices of activation. The first and most important conclusion of this work is that triple-helical peptides, even (GPO) 6 , do not support signalling unless they are cross-linked, with the exception of monomeric CRP, which induces modest tyrosine phosphorylation. The capacity of cross-linked GPO motifs to elicit these responses increased with the length of the GPO motif, in line with the capacity of the peptides to support platelet adhesion (see Figure 3b) . These data lead us to the R.W. Farndale et al. Table 1 Peptides used to examine GpVI recognition in platelets. Peptides were synthesized that had a conserved length (37 residues) and variable numbers of GPO triplets as indicated. They can be used in monomeric, triple-helical form to coat the surface of 96-well plates for platelet adhesion studies, and when cross-linked they can also be used to elicit signals from platelet suspensions (see Figure 3) . Peptide
conclusion that occupancy of GpVI alone is not a sufficient stimulus to support platelet activation, but that clustering of receptors is necessary, which can be induced by the application of cross-linked peptides. Thus the signals induced by monomeric CRP may in fact reflect the capacity of this quite long structure to accommodate more than one GpVI dimer, allowing it to promote bridging between multiple copies of GpVI and so fulfil the need for receptor clustering.
The requirement among the model peptides for this higher-order structure also applies to the parent collagens themselves: monomeric collagens produced by pepsin digestion will support adhesion of platelets and other cells, but not platelet aggregation. Native collagen fibres, however, expressing multiple copies of the GpVI recognition motif upon their surface along with the integrin motifs that firmly anchor the platelet, are potent platelet agonists. Peptides are defined in Table 1 . A-F have 0, 1, 2, 4, 6 and 10 GPO triplets respectively; G and H have 2 and 4 triplets respectively in two separate GPO motifs. (a) Experiments were performed as described in [52] in the presence of a fibrinogen receptor antagonist to prevent activation-dependent adhesion. Adhesion was GpVI-dependent, as demonstrated using blocking antibodies (not shown). (b) Dose of peptide is shown in g/ml. Peptide B, containing a single GPO, is silent, despite being cross-linked, whereas peptide C, having two GPO triplets, shows modest activity compared with the high levels of tyrosine phosphorylation induced by peptide H (CRP-XL; 5 g/ml). Experiments were performed by treating platelets in suspension with peptides for 3 min at 37ЊC, and using monoclonal antibody 4G10 to detect tyrosine phosphorylation in Western blots as described in [53] . Downstream lie a series of adaptor proteins [LAT (linker for activation of T cells), SLP76 (SH2-domain-containing leucocyte protein of 76 kDa) and several others] which, with phosphoinositide 3-kinase, lead to the activation of phospholipase C␥2 and the hydrolysis of inositol lipids, so generating a Ca 2+ signal. Recent interest surrounds the five dimorphisms of GpVI, which are grouped as two major alleles, designated a and b. One dimorphism leads to the expression of Pro rather than Ser in the pericellular stem of GpVI, and forms part of the b allele, which has been linked with increased risk of myocardial infarction [30] . Surprisingly, recent data show that b/b platelets are in fact less responsive to collagen and to CRP than the a/a genotype, with the dose-response curve shifted approx. 4-fold to the right, whereas their response to non-collagenous agonists was not impaired [49] . The underlying cause of this effect remains to be determined.
The question of whether integrin ␣2␤1 also signals in the setting of the platelet-collagen interaction is both interesting and topical. A wealth of literature concerning other cells supports the concept of bi-directional signalling through integrins, leading to changes both in the affinity of the receptor and in cell function [50] . Mainly, the outside-in component of integrin signalling is a rather slow process, providing input that is, for example, essential for cell growth or survival. It is thus not obvious that integrin ␣2␤1 has a signalling role in platelets, where rather rapid responses are required.
Recent unpublished data from our group have shown that integrin ␣2␤1 may re-inforce signals that arise through platelet GpVI under arterial shear conditions, observed at the level of Ca 2ϩ signalling and the expression of a procoagulant surface (P.R.-M. Siljander, I.C.A. Munnix, P.A. Smethurst, H. Deckmyn, T. Lindhout, W.H. Ouwehand, R.W. Farndale and J.W.M. Heemskerk, unpublished work). These responses were attenuated, but not abolished, by the use of GFOGER-containing peptides or ␣2␤1-specific antibodies to block the integrin in platelets deposited on collagen fibres. The precise relationship between GpVI and integrin ␣2␤1 remains to be defined.
Signals arising directly from integrin occupancy by collagen are much harder to observe, however. The application of the integrin ␣2␤1-specific peptide GFOGER to platelets in suspension causes no obvious general increase in protein tyrosine phosphorylation. However, we have found that the p38 mitogen-activated protein kinase (MAP kinase) becomes phosphorylated (and presumably activated) after treatment of platelets with peptides containing integrin ␣2␤1 recognition motifs. Collagen monomers, fibres and cross-linked GFOGER (the latter unpublished data are shown in Figure 5 ) were each able to promote p38 phosphorylation, an effect that peaked at 2 min and then declined quickly to basal levels. Moreover, the GpVI-specific CRP caused p38 phosphorylation without inducing subsequent loss of activity, suggesting that the dephosphorylation event is mediated by engagement of ␣2␤1 specifically. The decline in phosphorylation levels correlates with the association of protein phosphatase 2A with the p38 MAP kinase [51] , and can be blocked by integrin-specific antibodies ( Figure 5) as well as by cell-permeant peptides whose sequence corresponds to the cytoplasmic tail of the ␣2 integrin subunit. Despite these findings that convergent signals (the activation of p38) may arise through either of the two collagen receptors, GpVI and integrin ␣2␤1, discrimination of their roles can be observed at the level of signal termination by protein phosphatase 2A.
Conclusion
The data discussed above emphasize the importance of the platelet-collagen interaction in thrombosis and haemostasis, and the peptide tools described here may prove useful in identifying specific signalling pathways and thus specific targets for anti-thrombotic therapy. Phospho-p38 (ϩanti-␣2) Figure 5 Activation of p38 MAP kinase by integrin ligation. Platelet suspensions were treated with cross-linked triple-helical GFOGER for the indicated times, with and without preincubation with the anti-␣2 monoclonal antibody, 6F1. Phosphorylation levels, measured as the phospho-form of the enzyme in Western blots [51] , peaked at 2 min then declined in controls, whereas integrin blockade prevented the dephosphorylation of p38.
